Coley Pharmaceutical Group's Series D Round

Coley Pharmaceutical Group raised a round of funding on November 06, 2000.

Coley Pharmaceutical Group was engaged in the research and development of Toll-like receptor drugs to modulate the immune system for treating cancer, infectious diseases and asthma/allergy.…

Articles about Coley Pharmaceutical Group's Series D Round: